Drugs Made In America Acquisition II Corp.
DMII
$10.01
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | 9,473.59% | -21.26% | 35.75% | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -5,701.91% | -266.74% | -- | ||
| Change in Net Operating Assets | 85.97% | -4,735.90% | -123.73% | ||
| Cash from Operations | 54.41% | -26,465.38% | 74.00% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 100.00% | -- | -- | ||
| Cash from Investing | 100.00% | -- | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 100.00% | -- | -- | ||
| Issuance of Common Stock | -100.00% | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 100.00% | -- | -- | ||
| Cash from Financing | -100.00% | -- | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -201.35% | 12,050.00% | 74.00% | ||